BioCentury | Jul 15, 2020
Product Development
University of Queensland COVID-19 vaccine becomes seventh with CEPI funding to enter the clinic
...nasal and parenteral delivery. TNX-2300 is Tonix’s second live viral vector COVID-19 vaccine. The first, TNX-1800...
